Year |
Citation |
Score |
2021 |
Reichel FF, Michalakis S, Wilhelm B, Zobor D, Muehlfriedel R, Kohl S, Weisschuh N, Sothilingam V, Kuehlewein L, Kahle N, Seitz I, Paquet-Durand F, Tsang SH, Martus P, Peters T, et al. Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial. The British Journal of Ophthalmology. PMID 34006508 DOI: 10.1136/bjophthalmol-2021-319067 |
0.442 |
|
2021 |
Kahle N, Peters T, Braun A, Franklin J, Michalik C, Gekeler F, Wilhelm B. [Transcorneal electrostimulation in retinitis pigmentosa : Protocol of a multicentric prospective, randomized, controlled and double-masked trial on behalf of the Joint Federal Committee (G-BA pilot regulation)]. Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft. PMID 33740090 DOI: 10.1007/s00347-021-01360-1 |
0.42 |
|
2019 |
Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt KU, et al. Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical Trial. Jama Ophthalmology. PMID 31465092 DOI: 10.1001/Jamaophthalmol.2019.3278 |
0.431 |
|
2018 |
Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt K, et al. CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA. Retina (Philadelphia, Pa.). PMID 30308560 DOI: 10.1097/Iae.0000000000002360 |
0.424 |
|
Show low-probability matches. |